An Asprin a day will protect you from Myocardial Infarction: Asprin (acetyl salicylic acid) improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 31/January/2015, 16.52

Natural product-based therapy for life span extension: 6-shogaol, a natural compound isolated from Ginger, increases life span of mammals via down regulation of its target gene, 30/January/2014, 19.20
January 30, 2015
Natural product-based therapy for pulmonary arterial hypertension: Ankaflavin inhibits the development of pulmonary arterial hypertension via up regulation of its target gene, 31/January/2014, 17.30
January 31, 2015
Show all

A recent study from the Institute for Cardiovascular RegenerationCentre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature [I.F: >42] by Prof Dimmler, Boon, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: An Asprin a day will protect you from  Myocardial Infarction: Asprin (acetyl salicylic acid) improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10). It has been shown earlier that taking low doses of asprin can protect one from myocaridal diseases. However, the detailed mechanistic insight into how asprin protects one from myocaridal diseases is far from clear. This study suggests, for the first time, that asprin, by increasing the expression of PNUTS/PPP1R10, it may: (1) inhibit DNA damage responses, (2) inhibit telomere shortening; and (3) promote cardimyocyte survival. Therefore, by taking low doses of asprin, one may protect himself/herself from ageing-associated decline in cardiac function.  Together, this study suggests, for the first time, with a detailed mechanistic insight, that pharmacological formulations encompassing asprin  or its analogues” may be used to improve cardiac function after myocardial infarction. Based on this finding, Physicians may consider encouraging their cardiac patients to consume limited amount of asprin, to protect themselves from heart diseases. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  An Asprin a day will protect you from  Myocardial Infarction: Asprin (acetyl salicylic acid) improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 31/January/2015,  16.52,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.